Opterion Health 宣布 OPT101 的 1 期临床试验结果积极，支持推进至 2a 期研究

Phase 1positiveOPT101Positive

AI Analysis

Summary

Opterion Health announced positive Phase 1 results for OPT101, a non-glucose-based peritoneal dialysis therapy, with the SPARC study meeting all objectives and supporting progression to Phase 2a.

Clinical Trial Data

Phase

Phase 1

Primary Endpoint

Met

Outcome Details

SPARC study met all primary objectives, supporting advancement to Phase 2a

Importance:6/10

Sentiment:

0.85

Phase 1 DataPeritoneal DialysisNon-glucose-basedClinical Trial Advancement

Read the original article

Published by GlobeNewswire Clinical Studies on September 22, 2026 11:55 PM

Read Original